Patient preferences for rectal cancer treatment options and quality of life

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The study looks for adults with newly found rectal cancer that can be operated on. It also looks for doctors who treat rectal cancer. Both groups answer online questionnaires.

Age

Adults older than 18 years

Sex

All sexes can join

Disease stage

Patients: new rectal cancer that can be operated on, without metastasis and not a recurrent tumour

Main reasons for not taking part

• Cannot sign a consent form
• Cancer that has spread (metastasis)
• Recurrent tumour
• Cannot answer questionnaires on an online platform
• Cannot communicate in French or English

The registry criteria, word for word

What the trial wants to find out

This study is aiming to look into patients' treatment preferences and their socio economic background as well as the exploration of thought processes leading to these preferences. It will integrate, in two exploratory questionnaires, the three most common treatment schema (standard of care, non-operative management, surgery alone) all of which have been demonstrated efficacious.

The 2 groups in the trial

• Group A: Patients

  Recruitment for this group will take place at either the radiation-oncology department or at the colorectal surgery department, at the time of consultation or at the time of diagnosis, before the treatment setting. Once clinical staging is available, the surgeon and/or radiation-oncologist and/or research assistant should identify eligible patients. Patients that comply with selection criteria (inclusion/exclusion) will be approached by a research team member. For those patients interested in participating, the e-link to the consent form for this group will be sent by email. Once a patient decides to sign the consent form, the link for the questionnaire Q1 will be sent by email.

  Treatment: The only intervention will be the information brochure that will be given after the first questionnaire.

• Group B: Physicians

  Health professionals will be approached by the research team. The study aim will be explained, and participants that agree to participate will be provided an e-link to consent for this group. Once the health care participant decides to sign the consent form, the link for the questionnaire Q1 will be sent by email.

  Treatment: The only intervention will be the information brochure that will be given after the first questionnaire.